Trials / Completed
CompletedNCT04774328
Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair
A Three-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics, and Preliminary Efficacy Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Concentric Analgesics · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A Three-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics, and Preliminary Efficacy Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CA-008 (vocacapsaicin) | Single administration of CA-008 (vocacapsaicin) versus placebo |
| DRUG | Placebo | Single administration of CA-008 (vocacapsaicin) versus placebo |
Timeline
- Start date
- 2020-09-09
- Primary completion
- 2021-06-15
- Completion
- 2021-06-15
- First posted
- 2021-03-01
- Last updated
- 2022-09-14
- Results posted
- 2022-09-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04774328. Inclusion in this directory is not an endorsement.